Inhibitors of Lysinoalanine Cross-Linking in the Flagella Hook as Antimicrobials against Spirochetes
ACS Chemical Biology · 2025-03-21 · 20 (3) · 620-631
DOI: 10.1021/acschembio.4c00749 ↗At a glance
Journal article in ACS Chemical Biology, published online on 2025-02-25. Written by Michael J Lynch and 5 co-authors. Institution: Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States. Major MEDLINE topics: Flagella, Lysinoalanine. Cited 6 times so far (Crossref); 42 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, NIGMS NIH HHS, NIDCR NIH HHS.
Abstract (original language)
Spirochetes are especially invasive bacteria that are responsible for several human diseases, including Lyme disease, periodontal disease, syphilis, and leptospirosis. Spirochetes rely on an unusual form of motility based on periplasmic flagella (PFs) to infect hosts and evade the immune system. The flexible hook of these PFs contains a post-translational modification in the form of a lysinoalanine (Lal) cross-link between adjacent subunits of FlgE, which primarily comprise the hook. Lal cross-linking has since been found in key species across the phylum and involves residues that are highly conserved. The requirement of the Lal cross-link for motility of the pathogens Treponema denticola (Td) and Borreliella burgdorferi (Bb) establish Lal as a potential therapeutic target for the development of antimicrobials. Herein, we present the design, development, and application of a NanoLuc-based high-throughput screen that was used to successfully identify two structurally related Lal cross-link inhibitors (hexachlorophene and triclosan) from a library of clinically approved small molecules. A structure-activity relationship study further expanded the inhibitor set to a third compound (dichlorophene), and each inhibitor was demonstrated to biochemically block autocatalytic cross-linking of FlgE from several pathogenic spirochetes with varied mechanisms and degrees of specificity. The most potent inhibitor, hexachlorophene, alters Lal cross-linking in cultured cells of Td and reduces bacterial motility in swimming plate assays. Overall, these results provide a proof-of-concept for the discovery and development of Lal-cross-link inhibitors to combat spirochete-derived illnesses.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States.
- Philips Institute for Oral Health Research, Virginia Commonwealth University School of Dentistry, Richmond, Virginia 23298, United States.
- Department of Microbiology, Immunology, and Cell Biology, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, West Virginia 26506, United States.
ORCID profiles: Brian R Crane
Funding
- NIAID NIH HHS
- NIGMS NIH HHS
- NIDCR NIH HHS
- Bay Area Lyme Foundation
- National Institutes of Health
Cite
APA
Lynch, M. J., Kurniyati, K., Deshpande, M., Charon, N. W., Li, C., & Crane, B. R. (2025). Inhibitors of Lysinoalanine Cross-Linking in the Flagella Hook as Antimicrobials against Spirochetes. ACS Chemical Biology, 20(3), 620-631. https://doi.org/10.1021/acschembio.4c00749
Vancouver
Lynch MJ, Kurniyati K, Deshpande M, Charon NW, Li C, Crane BR. Inhibitors of Lysinoalanine Cross-Linking in the Flagella Hook as Antimicrobials against Spirochetes. ACS Chemical Biology. 2025;20(3):620-631. doi:10.1021/acschembio.4c00749
BibTeX
@article{Lynch2025,
author = {Lynch, Michael J and Kurniyati, Kurni and Deshpande, Maithili and Charon, Nyles W and Li, Chunhao and Crane, Brian R},
title = {Inhibitors of Lysinoalanine Cross-Linking in the Flagella Hook as Antimicrobials against Spirochetes},
journal = {ACS Chemical Biology},
year = {2025},
volume = {20},
number = {3},
pages = {620--631},
doi = {10.1021/acschembio.4c00749}
}
EUVIMED